FDA expands roflumilast cream approval to children as young as 2 years with plaque psoriasisByMorgan Ebert, Executive EditorJune 29th 2026
Sequential bilateral TMS linked to improvement in youth treatment-resistant depressionByMorgan Ebert, Executive EditorJune 29th 2026
AAP updates guidance on pediatric iron deficiency screening and treatmentByMorgan Ebert, Executive EditorJune 29th 2026
FDA approves risankizumab for pediatric plaque psoriasis and psoriatic arthritisByMorgan Ebert, Executive EditorJune 26th 2026